LOADING
Comparing Microsoft Corporation (MSFT) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | TMO |
|---|---|---|
| Price | $395.55 | $464.37 |
| Change Today | -1.57% | -2.32% |
| Market Cap | $2.94T | $172.5B |
| P/E Ratio | 24.8 | 26.2 |
| Forward P/E | 21.0 | 18.7 |
| PEG Ratio | 1.31 | 1.71 |
| EPS | $15.98 | $17.74 |
| Revenue Growth (YoY) | 16.7% | 7.2% |
| Profit Margin | 39.0% | 15.0% |
| Return on Equity | 34.4% | 13.0% |
| Dividend Yield | 0.87% | 0.36% |
| Beta | 1.11 | 0.97 |
| 52-Week High | $552.24 | $643.35 |
| 52-Week Low | $342.17 | $384.44 |
| Volume | 26.8M | 3.0M |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Microsoft Corporation offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.